ClinicalTrials.Veeva

Menu

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

The University of Chicago logo

The University of Chicago

Status

Not yet enrolling

Conditions

Acute Lymphoblastic Leukemia

Treatments

Other: High Intensity
Other: Low Intensity Text Messaging
Other: No Text Messagings

Study type

Interventional

Funder types

Other

Identifiers

NCT06446661
IRB23-1519

Details and patient eligibility

About

The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).

Full description

This study aims to compare adherence to oral mercaptopurine and methotrexate during the first 84-day cycle of maintenance therapy for adolescent and young adult patients with Acute Lymphoblastic Leukemia on pediatric-based regimens between those who receive the high intensity text message intervention and those who receive standard-of-care. It is believed that high-intensity text messages will increase patient adherence within cycle 1.

Enrollment

38 estimated patients

Sex

All

Ages

15 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of 15-39 years-old at the time of initial ALL diagnosis
  • Diagnosed with ALL
  • Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance.

Exclusion criteria

  • Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
  • Patient does not wish to participate
  • Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement.

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

38 participants in 2 patient groups

High Intensity
Active Comparator group
Description:
Receives high-intensity text messaging for 2 cycles of treatment
Treatment:
Other: High Intensity
Low Intensity
Active Comparator group
Description:
Receives no texts for 1st cycle and low-intensity texts for 2nd cycle
Treatment:
Other: No Text Messagings
Other: Low Intensity Text Messaging

Trial contacts and locations

1

Loading...

Central trial contact

Clinical Trials Intake

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems